P

Inventor

RAMAKRISHNAN BOOPATHY

US27 patents
⚠️ This page may combine multiple inventors who share the name “RAMAKRISHNAN BOOPATHY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VISTERRA INC

21 patents
US11136385B2Oct 5, 2021

Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule

VISTERRA INC4 citations83
US10954296B2Mar 23, 2021

Method of using anti-APRIL (a proliferation-inducing ligand) antibodies to reduce IGA

VISTERRA INC4 citations83
US10385123B2Aug 20, 2019

Antibody molecules to a proliferation-inducing ligand (APRIL)

VISTERRA INC8 citations83
US10981982B2Apr 20, 2021

Nucleic acid molecules encoding antibodies to a proliferation-inducing ligand (APRIL)

VISTERRA INC1 citations72
US10968270B2Apr 6, 2021

Antibody molecules to a proliferation-inducing ligand (APRIL)

VISTERRA INC3 citations72
US11912781B2Feb 27, 2024

Humanized complement 5A receptor 1 antibodies and methods of use thereof

VISTERRA INC1 citations71
US11168131B2Nov 9, 2021

Antibody molecule-drug conjugates and uses thereof

VISTERRA INC4 citations69
US12415865B2Sep 16, 2025

Antibody molecules to C5AR1 and uses thereof

VISTERRA INC0 citations61
US12187807B2Jan 7, 2025

Antibody molecules to C5AR1 and uses thereof

VISTERRA INC0 citations61
US12091451B2Sep 17, 2024

Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)

VISTERRA INC0 citations61
US11773179B2Oct 3, 2023

Antibody molecules to C5aR1 and uses thereof

VISTERRA INC0 citations61
US12338291B2Jun 24, 2025

Humanized antibody molecules to CD138 and uses thereof

VISTERRA INC0 citations60
US12264203B2Apr 1, 2025

Humanized complement 5a receptor 1 antibodies and methods of use thereof

VISTERRA INC0 citations60
US12227587B2Feb 18, 2025

Humanized complement 5A receptor 1 antibodies and methods of use thereof

VISTERRA INC0 citations60
US12297249B2May 13, 2025

Interleukin-2 agents and uses thereof

VISTERRA INC0 citations59
US12084484B2Sep 10, 2024

Interleukin-2 agents and uses thereof

VISTERRA INC0 citations59
US11945868B2Apr 2, 2024

Antibody molecules to CD138 and uses thereof

VISTERRA INC1 citations59
US11858980B2Jan 2, 2024

Engineered polypeptides and uses thereof

VISTERRA INC0 citations59
US12098178B2Sep 24, 2024

Methods of using interleukin-2 agents

VISTERRA INC0 citations54
US11890319B2Feb 6, 2024

Antibody molecule-drug conjugates and uses thereof

VISTERRA INC0 citations49
US11969476B2Apr 30, 2024

Antibody molecule-drug conjugates and uses thereof

VISTERRA INC0 citations46

QASBA PRADMAN K

3 patents

US HEALTH

2 patents

QASBA PRADMAN

1 patent